Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Net Debt history
Currency unavailable · from the balance sheet
No Net Debt data reported for this period type.
Net Debt vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | -$13.2M USD | +19.8% | — | 5.1% |
| Mar 2026 | -$40.96M USD | +59.1% | — | 9.4% | |
| Mar 2026 | -$50.12M USD | -14.5% | — | 12.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | -$67.25M USD | -35.1% | — | 13.5% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | -$146.66M USD | -16.5% | — | 95.3% |
| Mar 2026 | -$242.22M USD | +0.8% | — | 88.0% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | -$317.21M USD | -2931.4% | — | 80.6% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -14.5% | — | 13.5% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.